[HTML] rsc.org

[HTML][HTML] Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan, L Chen… - RSC …, 2019 - pubs.rsc.org
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant
proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated …
被引用次数：6 相关文章

[引用][C] Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan… - RSC …, 2019 - ui.adsabs.harvard.edu
Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by
modulating a PTEN/NF-κB/PRL-3 pathway - NASA/ADS Now on home page ads icon ads …

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway.

C Zhang, J Zhou, J Hu, S Lei, M Yuan, L Chen… - RSC …, 2019 - europepmc.org
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant
proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated …
[PDF] archive.org

[PDF][PDF] Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-kB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan, L Chen… - scholar.archive.org
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant
proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated …

Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan… - RSC …, 2019 - pubmed.ncbi.nlm.nih.gov
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant
proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated …
[HTML] nih.gov

[HTML][HTML] Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan, L Chen… - RSC …, 2019 - ncbi.nlm.nih.gov
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant
proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated …

[引用][C] Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

C Zhang, J Zhou, J Hu, S Lei, M Yuan, L Chen, G Wang… - 2019